Report Detail
Global (United States, European Union and China) Cancer Biological Therapy Market Research Report 2019-2025
- RnM3703835 |
- 28 August, 2019 |
- Global |
- 127 Pages |
- QYResearch |
- Pharma & Healthcare
Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and so on. Biological therapy utilizes the body’s immune system either directly or indirectly in order to fight cancer. Some biological therapies for cancer use vaccines or bacteria to stimulate the body’s immune system to act against cancer cells where as some therapies involve antibodies.
North America dominates a major share of the global Cancer Biological Therapy market
On the other hand, Asia pacific is projected to develop at a highest rate owing to growingoccurrence of cancer, large patient pool, improving healthcare facilities, etc.
In 2019, the market size of Cancer Biological Therapy is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Cancer Biological Therapy.
This report studies the global market size of Cancer Biological Therapy, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Cancer Biological Therapy sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
ELI Lilly
Sanofi
Merck
Bayer
Roche
Novartis International
Pfizer
Bristol-Myers Squibb
Seattle Genetics
Amgen
Takeda Pharmaceuticals
GlaxoSmithKline
Spectrum Pharmaceuticals
Celgene Corporation
AstraZeneca, Plc.
Otsuka
Eisai
Abbvie
Incyte
Market Segment by Product Type
Monoclonal Antibodies
Vaccines
Cancer Growth Blockers
Blood Cell Growth Factors
Market Segment by Application
Hospitals
Diagnostic Laboratories
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Cancer Biological Therapy status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Cancer Biological Therapy manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Cancer Biological Therapy are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Cancer Biological Therapy Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Monoclonal Antibodies
- 1.3.3 Vaccines
- 1.3.4 Cancer Growth Blockers
- 1.3.5 Blood Cell Growth Factors
- 1.4 Market Segment by Application
- 1.4.1 Global Cancer Biological Therapy Market Share by Application (2019-2025)
- 1.4.2 Hospitals
- 1.4.3 Diagnostic Laboratories
- 1.4.4 Research & Academic Laboratories
- 1.4.5 Pharmaceutical & Biotechnology Companies
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Cancer Biological Therapy Market Size
- 2.1.1 Global Cancer Biological Therapy Revenue 2014-2025
- 2.1.2 Global Cancer Biological Therapy Sales 2014-2025
- 2.2 Cancer Biological Therapy Growth Rate by Regions
- 2.2.1 Global Cancer Biological Therapy Sales by Regions 2014-2019
- 2.2.2 Global Cancer Biological Therapy Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Cancer Biological Therapy Sales by Manufacturers
- 3.1.1 Cancer Biological Therapy Sales by Manufacturers 2014-2019
- 3.1.2 Cancer Biological Therapy Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Cancer Biological Therapy Revenue by Manufacturers (2014-2019)
- 3.2.2 Cancer Biological Therapy Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Cancer Biological Therapy Market Concentration Ratio (CR5 and HHI)
- 3.3 Cancer Biological Therapy Price by Manufacturers
- 3.4 Key Manufacturers Cancer Biological Therapy Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Cancer Biological Therapy Market
- 3.6 Key Manufacturers Cancer Biological Therapy Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Monoclonal Antibodies Sales and Revenue (2014-2019)
- 4.1.2 Vaccines Sales and Revenue (2014-2019)
- 4.1.3 Cancer Growth Blockers Sales and Revenue (2014-2019)
- 4.1.4 Blood Cell Growth Factors Sales and Revenue (2014-2019)
- 4.2 Global Cancer Biological Therapy Sales Market Share by Type
- 4.3 Global Cancer Biological Therapy Revenue Market Share by Type
- 4.4 Cancer Biological Therapy Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Cancer Biological Therapy Sales by Application
6 United States
- 6.1 United States Cancer Biological Therapy Breakdown Data by Company
- 6.2 United States Cancer Biological Therapy Breakdown Data by Type
- 6.3 United States Cancer Biological Therapy Breakdown Data by Application
7 European Union
- 7.1 European Union Cancer Biological Therapy Breakdown Data by Company
- 7.2 European Union Cancer Biological Therapy Breakdown Data by Type
- 7.3 European Union Cancer Biological Therapy Breakdown Data by Application
8 China
- 8.1 China Cancer Biological Therapy Breakdown Data by Company
- 8.2 China Cancer Biological Therapy Breakdown Data by Type
- 8.3 China Cancer Biological Therapy Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Cancer Biological Therapy Breakdown Data by Company
- 9.2 Rest of World Cancer Biological Therapy Breakdown Data by Type
- 9.3 Rest of World Cancer Biological Therapy Breakdown Data by Application
- 9.4 Rest of World Cancer Biological Therapy Breakdown Data by Countries
- 9.4.1 Rest of World Cancer Biological Therapy Sales by Countries
- 9.4.2 Rest of World Cancer Biological Therapy Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 ELI Lilly
- 10.1.1 ELI Lilly Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.1.4 Cancer Biological Therapy Product Introduction
- 10.1.5 ELI Lilly Recent Development
- 10.2 Sanofi
- 10.2.1 Sanofi Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.2.4 Cancer Biological Therapy Product Introduction
- 10.2.5 Sanofi Recent Development
- 10.3 Merck
- 10.3.1 Merck Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.3.4 Cancer Biological Therapy Product Introduction
- 10.3.5 Merck Recent Development
- 10.4 Bayer
- 10.4.1 Bayer Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.4.4 Cancer Biological Therapy Product Introduction
- 10.4.5 Bayer Recent Development
- 10.5 Roche
- 10.5.1 Roche Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.5.4 Cancer Biological Therapy Product Introduction
- 10.5.5 Roche Recent Development
- 10.6 Novartis International
- 10.6.1 Novartis International Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.6.4 Cancer Biological Therapy Product Introduction
- 10.6.5 Novartis International Recent Development
- 10.7 Pfizer
- 10.7.1 Pfizer Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.7.4 Cancer Biological Therapy Product Introduction
- 10.7.5 Pfizer Recent Development
- 10.8 Bristol-Myers Squibb
- 10.8.1 Bristol-Myers Squibb Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.8.4 Cancer Biological Therapy Product Introduction
- 10.8.5 Bristol-Myers Squibb Recent Development
- 10.9 Seattle Genetics
- 10.9.1 Seattle Genetics Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.9.4 Cancer Biological Therapy Product Introduction
- 10.9.5 Seattle Genetics Recent Development
- 10.10 Amgen
- 10.10.1 Amgen Company Details
- 10.10.2 Company Description and Business Overview
- 10.10.3 Sales, Revenue and Market Share of Cancer Biological Therapy
- 10.10.4 Cancer Biological Therapy Product Introduction
- 10.10.5 Amgen Recent Development
- 10.11 Takeda Pharmaceuticals
- 10.12 GlaxoSmithKline
- 10.13 Spectrum Pharmaceuticals
- 10.14 Celgene Corporation
- 10.15 AstraZeneca, Plc.
- 10.16 Otsuka
- 10.17 Eisai
- 10.18 Abbvie
- 10.19 Incyte
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Cancer Biological Therapy Sales Channels
- 11.2.2 Cancer Biological Therapy Distributors
- 11.3 Cancer Biological Therapy Customers
12 Market Forecast
- 12.1 Global Cancer Biological Therapy Sales and Revenue Forecast 2019-2025
- 12.2 Global Cancer Biological Therapy Sales Forecast by Type
- 12.3 Global Cancer Biological Therapy Sales Forecast by Application
- 12.4 Cancer Biological Therapy Forecast by Regions
- 12.4.1 Global Cancer Biological Therapy Sales Forecast by Regions 2019-2025
- 12.4.2 Global Cancer Biological Therapy Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Biological Therapy. Industry analysis & Market Report on Cancer Biological Therapy is a syndicated market report, published as Global (United States, European Union and China) Cancer Biological Therapy Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Cancer Biological Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
